ArticleiScience2023

Rosiglitazone reduces diabetes angiopathy by inhibiting mitochondrial dysfunction dependent on regulating HSP22 expression.

Lingling Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.